A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors

Clinical trial NCT02318394 · COMPLETED

Trial details

NCT number: NCT02318394
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2015-03-02
Primary completion: 2018-01-09
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.